Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel and Gemcitabine in Metastatic or Recurrent SCLC
NCT00453167Phase 2Completed
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Start
- Dec 2005
- Primary completion
- Dec 2009
- Modality
- Cytokines & Interferons, Small Molecules, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of Paclitaxel Micelles for Injection, gemcitabine in small cell lung cancer (SCLC), sponsored by Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Started Dec 2005; status: completed.
02
Drugs
Paclitaxel Micelles for Injectiongemcitabine
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT00453167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00453167.